HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: IBDQ IN THE SEAVUE STUDY

Silvio Danese  1     Edward V. Loftus Jr  2     Remo Panaccione  3     Timothy Hoops  4     Tony Ma  4     Zhijie Ding  4     Erik Muser  4     Christopher Gasink  4     Matthieu Allez  5     William Sandborn  6     James Izanec  4     Peter Irving  7    
1 Humanitas Clinical and Research Center, Humanitas University, Milan, Italy
2 Mayo Clinic College of Medicine, Rochester, United States
3 University of Calgary, Calgary, Canada
4 Janssen Scientific Affairs, LLC, Horsham, United States
5 Université de Paris, Paris, France
6 University of California San Diego, San Diego, United States
7 Guy’s and Saint Thomas’ Hospitals NHS Trust, London, United Kingdom

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing